Novel evidence for oncogenic piRNA‐823 as a promising prognostic biomarker and a potential therapeutic target in colorectal cancer

piRNA‐823 as a member of the piRNA family is reported to promote tumour cell proliferation in multiple myeloma and hepatocellular cancer. However, few studies on the function of piRNA‐823 in colorectal cancer (CRC). Our present study data showed that piRNA‐823 plays an oncogene role in CRC cells. Inhibition of piRNA‐823 can significantly inhibit the proliferation, invasion and apoptosis resistance of CRC cells. Mechanism studies have shown that piRNA‐823 inhibits the ubiquitination of hypoxia‐inducible factor‐1 alpha (HIF‐1α) by up‐regulating the expression of Glucose‐6‐phosphate dehydrogenase (G6PD) and ultimately up‐regulates the glucose consumption of carcinoma cells and inhibits the content of intracellular reactive oxygen species (ROS). Therefore, we speculate piRNA‐823 promotes the proliferation, invasion and apoptosis resistance of CRC cells by regulating G6PD/HIF‐1α pathway. In this study, we set up the cancer‐promoting function recovery experiment of piRNA‐823 by silencing G6PD gene to confirm the dominance of the above‐mentioned pathways. Using clinical samples, we found that overexpression of piRNA‐823 correlated with poor overall survival and predicted a poor response to adjuvant chemotherapy of patients with CRC. In a word, our research has further enriched the theory of piRNA‐823 promoting the progression of CRC, and laid a solid foundation for the development of piRNA‐823‐based gene therapy for CRC and its use as a promising prognostic biomarker in CRC patients.

[1]  Xiumei Zhang,et al.  PAK4 regulates G6PD activity by p53 degradation involving colon cancer cell growth , 2017, Cell Death and Disease.

[2]  Marco Greco,et al.  Worldwide burden of colorectal cancer: a review , 2016, Updates in Surgery.

[3]  W. Lam,et al.  An atlas of gastric PIWI-interacting RNA transcriptomes and their utility for identifying signatures of gastric cancer recurrence , 2016, Gastric Cancer.

[4]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[5]  Dan-sen Wu,et al.  Effects of Novel ncRNA Molecules, p15‐piRNAs, on the Methylation of DNA and Histone H3 of the CDKN2B Promoter Region in U937 Cells , 2015, Journal of cellular biochemistry.

[6]  Tongzhang Zheng,et al.  PIWI-interacting RNA 021285 is involved in breast tumorigenesis possibly by remodeling the cancer epigenome. , 2015, Carcinogenesis.

[7]  Fabian J Theis,et al.  Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer , 2015, Molecular Cancer.

[8]  Maurizio Guida,et al.  Small non-coding RNA deregulation in endometrial carcinogenesis , 2015, Oncotarget.

[9]  A. Weisz,et al.  Timed regulation of P‐element‐induced wimpy testis–interacting RNA expression during rat liver regeneration , 2014, Hepatology.

[10]  K. Wang,et al.  piRNA-823 contributes to tumorigenesis by regulating de novo DNA methylation and angiogenesis in multiple myeloma , 2014, Leukemia.

[11]  Manhong Guo,et al.  Fighting an old war with a new weapon—silencing transposons by Piwi‐interacting RNA , 2013, IUBMB life.

[12]  S. Shen,et al.  Altered expression of piRNAs and their relation with clinicopathologic features of breast cancer , 2013, Clinical and Translational Oncology.

[13]  Y. Kirino,et al.  PIWI Expression and Function in Cancer , 2012, Front. Gene..

[14]  Jia Cheng,et al.  piR-823, a novel non-coding small RNA, demonstrates in vitro and in vivo tumor suppressive activity in human gastric cancer cells. , 2012, Cancer letters.

[15]  D. Dang,et al.  Oncogenic KRAS modulates mitochondrial metabolism in human colon cancer cells by inducing HIF-1α and HIF-2α target genes , 2010, Molecular Cancer.

[16]  B. Xiao,et al.  Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using piRNAs as markers. , 2010, Clinical biochemistry.

[17]  Lei Tang,et al.  The potential insulin sensitizing and glucose lowering effects of a novel indole derivative in vitro and in vivo. , 2007, Pharmacological research.

[18]  C. Sander,et al.  A novel class of small RNAs bind to MILI protein in mouse testes , 2006, Nature.

[19]  S. Loening,et al.  Identification and validation of suitable endogenous reference genes for gene expression studies of human bladder cancer. , 2006, The Journal of urology.

[20]  G. Semenza,et al.  Development of novel therapeutic strategies that target HIF-1 , 2006, Expert opinion on therapeutic targets.

[21]  A. Harris,et al.  Hypoxia‐inducible factor‐1α in non small cell lung cancer: Relation to growth factor, protease and apoptosis pathways , 2004, International journal of cancer.

[22]  M. Aschner,et al.  Methylmercury-induced reactive oxygen species formation in neonatal cerebral astrocytic cultures is attenuated by antioxidants. , 2003, Brain research. Molecular brain research.

[23]  정기동,et al.  Recurrence , 1946, Definitions.

[24]  A. Jemal,et al.  Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.

[25]  M. Siomi,et al.  piRNA biogenesis in the germline: From transcription of piRNA genomic sources to piRNA maturation. , 2016, Biochimica et biophysica acta.